Reversal of age-associated thymic atrophy: Treatments, delivery, and side effects

Experimental Gerontology

Volumn 43, Issue 7, 2008, Pages 700-705

  Aspinall, Richard ^a   Mitchell, Wayne ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Interleukin 7; Keratinocyte growth factor; Sex steroid intervention; Thymic atrophy

Indexed keywords

2 METHYLALANYL DEXTRO TRYPTOPHAN 1 FORMAMIDO 2 (3 INDOLYL)ETHYLAMIDE; ANTIANDROGEN; GHRELIN; GONADORELIN DERIVATIVE; GROWTH HORMONE; GROWTH HORMONE DERIVATIVE; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; LYMPHOCYTE ANTIGEN RECEPTOR; PALIFERMIN; RECOMBINANT INTERLEUKIN 7; SEX HORMONE;

ABSENCE OF SIDE EFFECTS; AGE; ANOREXIA; ARTHRALGIA; CARPAL TUNNEL SYNDROME; CASTRATION; DIARRHEA; ERYTHEMA; FEVER; FLU LIKE SYNDROME; GYNECOMASTIA; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOLOGY; IMPOTENCE; INFECTION SENSITIVITY; INJECTION SITE ERYTHEMA; MUCOSA INFLAMMATION; MYALGIA; NAUSEA; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PRURITUS; RASH; REGULATORY T LYMPHOCYTE; SHORT SURVEY; SOFT TISSUE DISEASE; SOFT TISSUE EDEMA; T LYMPHOCYTE; TASTE DISORDER; THYMUS ATROPHY; UNSPECIFIED SIDE EFFECT;

AGED; AGING; ANIMALS; ATROPHY; CASTRATION; FIBROBLAST GROWTH FACTOR 7; GONADAL STEROID HORMONES; GROWTH HORMONE; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-7; THYMUS GLAND;

EID: 46949110881     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2008.04.014     Document Type: Short Survey

References (76)

1. Andrew D., and Aspinall R. Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice. J. Immunol. 166 (2001) 1524-1530
2. Andrew D., and Aspinall R. Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp. Gerontol. 37 (2002) 455-463
3. Aspinall R., and Andrew D. Thymic atrophy in the mouse is a soluble problem of the thymic environment. Vaccine 18 (2000) 1629-1637
4. Aspinall R., Pido-Lopez J., Imami N., Henson S.M., Ngom P.T., Morre M., Niphuis H., Remarque E., Rosenwirth B., and Heeney J.L. Old Rhesus Macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination. Rejuvenation Res. 10 (2007) 5-18
5. Austad S., 1999. Why We Age: What Science Is Discovering about the Body's Journey Through Life. John Wiley & Sons, ISBN-10:0471296465.
6. Beentjes J.A., van Gorkom B.A., Sluiter W.J., de Vries E.G., Kleibeuker J.H., and Dullaart R.P. One year growth hormone replacement therapy does not alter colonic epithelial cell proliferation in growth hormone deficient adults. Clin. Endocrinol. (Oxf.) 52 (2000) 457-462
7. Beq S., Nugeyre M.T., Ho Tsong F.R., Gautier D., Legrand R., Schmitt N., Estaquier J., Barre-Sinoussi F., Hurtrel B., Cheynier R., and Israel N. IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. J. Immunol. 176 (2006) 914-922
8. Bruinsma M., van Soest P.L., Leenen P.J., Lambrecht B.N., Cupedo T., Lowenberg B., Cornelissen J.J., and Braakman E. Keratinocyte growth factor induces expansion of murine peripheral CD4+Foxp3+ regulatory T cells and increases their thymic output. J. Immunol. 179 (2007) 7424-7430
9. Chu Y.W., Memon S.A., Sharrow S.O., Hakim F.T., Eckhaus M., Lucas P.J., and Gress R.E. Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood 104 (2004) 1110-1119
10. Clarke D., Katoh O., Gibbs R.V., Griffiths S.D., and Gordon M.Y. Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance. Cytokine 7 (1995) 325-330
11. Dixit V.D., Yang H., Sun Y., Weeraratna A.T., Youm Y.H., Smith R.G., and Taub D.D. Ghrelin promotes thymopoiesis during aging. J. Clin. Invest. 117 (2007) 2778-2790
12. Douek D.C., McFarland R.D., Keiser P.H., Gage E.A., Massey J.M., Haynes B.F., Polis M.A., Haase A.T., Feinberg M.B., Sullivan J.L., Jamieson B.D., Zack J.A., Picker L.J., and Koup R.A. Changes in thymic function with age and during the treatment of HIV infection. Nature 396 (1998) 690-695
13. Drori D., and Folman Y. Environmental effects on longevity in the male rat: exercise, mating, castration and restricted feeding. Exp. Gerontol. 11 (1976) 25-32
14. El Kassar N., Lucas P.J., Klug D.B., Zamisch M., Merchant M., Bare C.V., Choudhury B., Sharrow S.O., Richie E., Mackall C.L., and Gress R.E. A dose effect of IL-7 on thymocyte development. Blood 104 (2004) 1419-1427
15. Finch P.W., and Rubin J.S. Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J. Natl. Cancer Inst. 98 (2006) 812-824
16. Fitzpatrick F.T., Kendall M.D., Wheeler M.J., Adcock I.M., and Greenstein B.D. Reappearance of thymus of ageing rats after orchidectomy. J. Endocrinol. 106 (1985) R17-R19
17. French R.A., Broussard S.R., Meier W.A., Minshall C., Arkins S., Zachary J.F., Dantzer R., and Kelley K.W. Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution. Endocrinology 143 (2002) 690-699
18. Fry T.J., and Mackall C.L. Interleukin-7 from bench to clinic. Blood 99 (2002) 3892-3904
19. Fry T.J., Moniuszko M., Creekmore S., Donohue S.J., Douek D.C., Giardina S., Hecht T.T., Hill B.J., Komschlies K., Tomaszewski J., Franchini G., and Mackall C.L. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 101 (2003) 2294-2299
20. Goldberg G.L., Alpdogan O., Muriglan S.J., Hammett M.V., Milton M.K., Eng J.M., Hubbard V.M., Kochman A., Willis L.M., Greenberg A.S., Tjoe K.H., Sutherland J.S., Chidgey A., Van Den Brink M.R., and Boyd R.L. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation. J. Immunol. 178 (2007) 7473-7484
21. Goldberg G.L., Zakrzewski J.L., Perales M.A., and Van Den Brink M.R. Clinical strategies to enhance T cell reconstitution. Semin. Immunol. 19 (2007) 289-296
22. Greenstein B.D., Fitzpatrick F.T., Adcock I.M., Kendall M.D., and Wheeler M.J. Reappearance of the thymus in old rats after orchidectomy: inhibition of regeneration by testosterone. J. Endocrinol. 110 (1986) 417-422
23. Habib T., Nelson A., and Kaushansky K. IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. J. Allergy Clin. Immunol. 112 (2003) 1033-1045
24. Hamilton J.B., and Mestler G.E. Mortality and survival: comparison of eunuchs with intact men and women in a mentally retarded population. J. Gerontol. 24 (1969) 395-411
25. Hare K.J., Jenkinson E.J., and Anderson G. An essential role for the IL-7 receptor during intrathymic expansion of the positively selected neonatal T cell repertoire. J. Immunol. 165 (2000) 2410-2414
26. Heng T.S., Goldberg G.L., Gray D.H., Sutherland J.S., Chidgey A.P., and Boyd R.L. Effects of castration on thymocyte development in two different models of thymic involution. J. Immunol. 175 (2005) 2982-2993
27. Henson S.M., Snelgrove R., Hussell T., Wells D.J., and Aspinall R. An IL-7 fusion protein that shows increased thymopoietic ability. J. Immunol. 175 (2005) 4112-4118
28. Hirokawa K., Utsuyama M., and Kobayashi S. Hypothalamic control of development and aging of the thymus. Mech. Ageing Dev. 100 (1998) 177-185
29. Hosseinzadeh H., and Goldschneider I. Recent thymic emigrants in the rat express a unique antigenic phenotype and undergo post-thymic maturation in peripheral lymphoid tissues. J. Immunol. 150 (1993) 1670-1679
30. Jenkins J.S. The voice of the castrato. Lancet 351 (1998) 1877-1880
31. Jiang Q., Li W.Q., Aiello F.B., Mazzucchelli R., Asefa B., Khaled A.R., and Durum S.K. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev. 16 (2005) 513-533
32. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., and Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4 (2003) 1191-1198
33. Kelley K.W., Brief S., Westly H.J., Novakofski J., Bechtel P.J., Simon J., and Walker E.B. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc. Natl. Acad. Sci. USA 83 (1986) 5663-5667
34. Kendall M.D., Fitzpatrick F.T., Greenstein B.D., Khoylou F., Safieh B., and Hamblin A. Reversal of ageing changes in the thymus of rats by chemical or surgical castration. Cell Tissue Res. 261 (1990) 555-564
35. Kimura K., Matsubara H., Sogoh S., Kita Y., Sakata T., Nishitani Y., Watanabe S., Hamaoka T., and Fujiwara H. Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor. J. Immunol. 146 (1991) 2618-2624
36. Koo G.C., Huang C., Camacho R., Trainor C., Blake J.T., Sirotina-Meisher A., Schleim K.D., Wu T.J., Cheng K., Nargund R., and McKissick G. Immune enhancing effect of a growth hormone secretagogue. J. Immunol. 166 (2001) 4195-4201
37. Liu H., Bravata D.M., Olkin I., Nayak S., Roberts B., Garber A.M., and Hoffman A.R. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann. Intern. Med. 146 (2007) 104-115
38. Loeffler J., Bauer R., Hebart H., Douek D.C., Rauser G., Bader P., and Einsele H. Quantification of T-cell receptor excision circle DNA using fluorescence resonance energy transfer and the LightCycler system. J. Immunol. Methods 271 (2002) 167-175
39. Maraskovsky E., Teepe M., Morrissey P.J., Braddy S., Miller R.E., Lynch D.H., and Peschon J.J. Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. J. Immunol. 157 (1996) 5315-5323
40. McFarland R.D., Douek D.C., Koup R.A., and Picker L.J. Identification of a human recent thymic emigrant phenotype. Proc. Natl. Acad. Sci. USA 97 (2000) 4215-4220
41. Melchionda F., Fry T.J., Milliron M.J., McKirdy M.A., Tagaya Y., and Mackall C.L. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8(+) memory cell pool. J. Clin. Invest. 115 (2005) 1177-1187
42. Michaelson M.D., Mehler M.F., Xu H., Gross R.E., and Kessler J.A. Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain. Dev. Biol. 179 (1996) 251-263
43. Min D., Panoskaltsis-Mortari A., Kuro O., Hollander G.A., Blazar B.R., and Weinberg K.I. Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood 109 (2007) 2529-2537
44. Min D., Taylor P.A., Panoskaltsis-Mortari A., Chung B., Danilenko D.M., Farrell C., Lacey D.L., Blazar B.R., and Weinberg K.I. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99 (2002) 4592-4600
45. Moniuszko M., Fry T., Tsai W.P., Morre M., Assouline B., Cortez P., Lewis M.G., Cairns S., Mackall C., and Franchini G. Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo. J. Virol. 78 (2004) 9740-9749
46. Moreau J.P., Delavault P., and Blumberg J. Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy. Clin. Ther. 28 (2006) 1485-1508
47. Morrissey P.J., Conlon P., Braddy S., Williams D.E., Namen A.E., and Mochizuki D.Y. Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation. J. Immunol. 146 (1991) 1547-1552
48. Msaouel P., Diamanti E., Tzanela M., and Koutsilieris M. Luteinising hormone-releasing hormone antagonists in prostate cancer therapy. Expert Opin. Emerg. Drugs 12 (2007) 285-299
49. Muegge K., Vila M.P., and Durum S.K. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. Science 261 (1993) 93-95
50. Munitic I., Williams J.A., Yang Y., Dong B., Lucas P.J., El Kassar N., Gress R.E., and Ashwell J.D. Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis. Blood 104 (2004) 4165-4172
51. Napolitano L.A., Lo J.C., Gotway M.B., Mulligan K., Barbour J.D., Schmidt D., Grant R.M., Halvorsen R.A., Schambelan M., and McCune J.M. Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS 16 (2002) 1103-1111
52. Nugeyre M.T., Monceaux V., Beq S., Cumont M.C., Ho Tsong F.R., Chene L., Morre M., Barre-Sinoussi F., Hurtrel B., and Israel N. IL-7 stimulates T cell renewal without increasing viral replication in simian immunodeficiency virus-infected macaques. J. Immunol. 171 (2003) 4447-4453
53. Oosterwegel M.A., Haks M.C., Jeffry U., Murray R., and Kruisbeek A.M. Induction of TCR gene rearrangements in uncommitted stem cells by a subset of IL-7 producing, MHC class-II-expressing thymic stromal cells. Immunity 6 (1997) 351-360
54. Ortman C.L., Dittmar K.A., Witte P.L., and Le P.T. Molecular characterization of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments. Int. Immunol. 14 (2002) 813-822
55. Permar S.R., Moss W.J., Ryon J.J., Douek D.C., Monze M., and Griffin D.E. Increased thymic output during acute measles virus infection. J. Virol. 77 (2003) 7872-7879
56. Pfister G., Weiskopf D., Lazuardi L., Kovaiou R.D., Cioca D.P., Keller M., Lorbeg B., Parson W., and Grubeck-Loebenstein B. Naive T cells in the elderly: are they still there?. Ann. NY Acad. Sci. 1067 (2006) 152-157
57. Phillips J.A., Brondstetter T.I., English C.A., Lee H.E., Virts E.L., and Thoman M.L. IL-7 gene therapy in aging restores early thymopoiesis without reversing involution. J. Immunol. 173 (2004) 4867-4874
58. Piccoli F., Degen L., MacLean C., Peter S., Baselgia L., Larsen F., Beglinger C., and Drewe J. Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects. J. Clin. Endocrinol. Metab. 92 (2007) 1814-1820
59. Pido-Lopez J., Imami N., Andrew D., and Aspinall R. Molecular quantitation of thymic output in mice and the effect of IL-7. Eur. J. Immunol. 32 (2002) 2827-2836
60. Revest J.M., Suniara R.K., Kerr K., Owen J.J., and Dickson C. Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb. J. Immunol. 167 (2001) 1954-1961
61. Rosenberg S.A., Sportes C., Ahmadzadeh M., Fry T.J., Ngo L.T., Schwarz S.L., Stetler-Stevenson M., Morton K.E., Mavroukakis S.A., Morre M., Buffet R., Mackall C.L., and Gress R.E. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J. Immunother. 29 (2006) 313-319
62. Salisbury, D., Ramsay, M., Noakes, K. (Eds.), 2006. Immunisation against infectious disease, third ed. The Stationery Office, ISBN-10 0-11-322528-8.
63. Scollay R.G., Butcher E.C., and Weissman I.L. Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur. J. Immunol. 10 (1980) 210-218
64. Seggewiss R., Lore K., Guenaga F.J., Pittaluga S., Mattapallil J., Chow C.K., Koup R.A., Camphausen K., Nason M.C., Meier-Schellersheim M., Donahue R.E., Blazar B.R., Dunbar C.E., and Douek D.C. Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood 110 (2007) 441-449
65. Sheppard M.C. Growth hormone therapy does not induce cancer. Nat. Clin. Pract. Endocrinol. Metab. 2 (2006) 532-533
66. Smith R.G. Development of growth hormone secretagogues. Endocr. Rev. 26 (2005) 346-360
67. Smith R.G., Jiang H., and Sun Y. Developments in ghrelin biology and potential clinical relevance. Trends Endocrinol. Metab. 16 (2005) 436-442
68. Sodora D.L., Douek D.C., Silvestri G., Montgomery L., Rosenzweig M., Igarashi T., Bernacky B., Johnson R.P., Feinberg M.B., Martin M.A., and Koup R.A. Quantification of thymic function by measuring T cell receptor excision circles within peripheral blood and lymphoid tissues in monkeys. Eur. J. Immunol. 30 (2000) 1145-1153
69. Spielberger R., Stiff P., Bensinger W., Gentile T., Weisdorf D., Kewalramani T., Shea T., Yanovich S., Hansen K., Noga S., McCarty J., LeMaistre C.F., Sung E.C., Blazar B.R., Elhardt D., Chen M.G., and Emmanouilides C. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N. Engl. J. Med. 351 (2004) 2590-2598
70. Storek J., Gillespy III T., Lu H., Joseph A., Dawson M.A., Gough M., Morris J., Hackman R.C., Horn P.A., Sale G.E., Andrews R.G., Maloney D.G., and Kiem H.P. Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys. Blood 101 (2003) 4209-4218
71. Sutherland J.S., Goldberg G.L., Hammett M.V., Uldrich A.P., Berzins S.P., Heng T.S., Blazar B.R., Millar J.L., Malin M.A., Chidgey A.P., and Boyd R.L. Activation of thymic regeneration in mice and humans following androgen blockade. J. Immunol. 175 (2005) 2741-2753
72. Swerdlow A.J., Higgins C.D., Adlard P., and Preece M.A. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 360 (2002) 273-277
73. Thoman M.L. Effects of the aged microenvironment on CD4+ T cell maturation. Mech. Ageing Dev. 96 (1997) 75-88
74. Toraldo G., Roggia C., Qian W.P., Pacifici R., and Weitzmann M.N. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc. Natl. Acad. Sci. USA 100 (2003) 125-130
75. Tornell J., Carlsson B., Pohjanen P., Wennbo H., Rymo L., and Isaksson O. High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice. J. Steroid Biochem. Mol. Biol. 43 (1992) 237-242
76. Welniak L.A., Sun R., and Murphy W.J. The role of growth hormone in T-cell development and reconstitution. J. Leukoc. Biol. 71 (2002) 381-387